WallStreetZenWallStreetZen

NASDAQ: IRIX
Iridex Corp Stock Ownership - Who owns Iridex?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iridex Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick MercerPresident and CEO2025-10-0123,850$1.13
$26.95kSell
Romeo R. DizonChief Financial Officer2025-09-121,200$1.36
$1.63kBuy
Romeo R. DizonChief Financial Officer2025-09-12250$1.37
$342.50Buy
Romeo R. DizonChief Financial Officer2025-09-11500$1.34
$670.00Buy
Romeo R. DizonChief Financial Officer2025-09-11250$1.35
$337.50Buy
Romeo R. DizonChief Financial Officer2025-09-11500$1.35
$674.50Buy
Romeo R. DizonChief Financial Officer2025-09-101,000$1.33
$1.33kBuy
Romeo R. DizonChief Financial Officer2025-09-10500$1.36
$680.00Buy
Romeo R. DizonChief Financial Officer2025-09-091,500$1.37
$2.06kBuy
Romeo R. DizonChief Financial Officer2025-09-08500$1.40
$700.00Buy

1 of 10

IRIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRIX insiders and whales buy or sell their stock.

IRIX Shareholders

What type of owners hold Iridex Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blueline Catalyst Fund IX LP15.06%2,559,122$2.69MInsider
Blueline Capital Partners II LP14.76%2,508,100$2.63MInsider
Blueline Partners LLC 114.62%2,483,815$2.61MInsider
Blueline Partners LLC14.51%2,465,222$2.59MInsider
Scott Shuda10.30%1,750,059$1.84MInsider
Topcon America Corp9.52%1,618,122$1.70MInsider
Associates Paragon Associates Ii Joint Venture Paragon7.77%1,320,000$1.39MInsider
Acuta Capital Fund LP6.81%1,157,011$1.21MInsider
Blueline Capital Partners LP6.70%1,138,862$1.20MInsider
Paragon Associates Paragon Associates II Joint Venture5.89%1,000,000$1.05MInstitution

1 of 3

IRIX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRIX12.20%87.80%Net BuyingNet Buying
CODX13.37%25.74%Net Selling
ADGM53.92%46.08%
COCH50.10%49.90%Net Buying
VVOS5.36%85.07%
View Top Medical Device Stocks

Iridex Stock Ownership FAQ

Who owns Iridex?

Iridex (NASDAQ: IRIX) is owned by 15.83% institutional shareholders, 113.93% Iridex insiders, and 0.00% retail investors. Blueline Catalyst Fund IX LP is the largest individual Iridex shareholder, owning 2.56M shares representing 15.06% of the company. Blueline Catalyst Fund IX LP's Iridex shares are currently valued at $2.69M.

If you're new to stock investing, here's how to buy Iridex stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.